3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma

NCT00075660 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

NETWORK

Sponsor class

Conditions

Kidney Cancer

Interventions

DRUG: triapine

Sponsor

NCIC Clinical Trials Group

Collaborators

[object Object]